title: Repeatability of pattern electroretinogram measurements using a new paradigm optimized for glaucoma detection.
abstract: OBJECTIVE
  To determine the within-trial and between-trial repeatability of pattern electroretinogram (PERG) measurements in healthy and patient eyes, using a new clinical instrument, the PERGLA.
  
  
  METHODS
  In all, 70 eyes of 35 healthy individuals (intraocular pressure <22 mm Hg, healthy optic disc by stereophotograph assessment, standard visual fields within normal limits) and 90 eyes of 45 clinic patients (ocular hypertensive, glaucomatous optic neuropathy by stereophotograph assessment and/or repeatable abnormal visual fields) enrolled in the University of California, San Diego Diagnostic Innovations in Glaucoma Study (DIGS) were evaluated. Average mean deviation of patient eyes on standard automated perimetry was -1.81 dB (SD=2.61).
  
  
  METHODS
  The PERG was recorded using the PERGLA paradigm from both eyes simultaneously twice (ie, 2 trials) by a single operator with electrodes being removed and reattached between recordings. Repeatability of PERG amplitude (microV) and phase (pi rad) between 2 runs within a single trial (within-trial condition) was compared with repeatability between 2 trials (ie, after electrode replacement, between-trial condition) by calculating the coefficients of variability (CVs) and the intraclass correlation coefficients (ICCs) and displaying Bland-Altman plots.
  
  
  RESULTS
  For healthy eyes, amplitude CVs (SD) were 11.5% (11.5) and 9.9% (0.79) for within-trial and between-trial conditions, respectively. ICCs were 0.91 and 0.85. Phase CVs were 1.3% (1.5) (within-trials) and 1.5% (1.4) (between-trials) and ICCs were 0.85 and 0.88. For patient eyes, amplitude CVs (SD) were 12.2% (10.1) and 11.2% (7.5) for within-trial and between-trial conditions, respectively. ICCs were 0.92 and 0.89. Phase CVs were 2.2% (2.2) (within-trials) and 2.4% (2.2) (between-trials) and ICCs were 0.82 and 0.83. Bland-Altman plots indicated good agreement between the repeated recordings and were similar within-trials and between-trials for healthy and patient eyes.
  
  
  CONCLUSIONS
  Repeatability of PERGLA recordings is good and is similar within-trials and between-trials for both healthy and patient eyes suggesting this technique is promising for monitoring change over time.
authors.affiliation: Hamilton Glaucoma Center, Department of Ophthalmology, University of California, San Diego, La Jolla, CA 92037-0946, USA. cbowd@glaucoma.ucsd.edu
authors.forename: Christopher
authors.initials: C
authors.lastname: Bowd
authors.forename: Ali
authors.initials: A
authors.lastname: Tafreshi
authors.forename: Gianmarco
authors.initials: G
authors.lastname: Vizzeri
authors.forename: Linda M
authors.initials: LM
authors.lastname: Zangwill
authors.forename: Pamela A
authors.initials: PA
authors.lastname: Sample
authors.forename: Robert N
authors.initials: RN
authors.lastname: Weinreb
mesh_terms: D000368:Aged; D004594:Electrophysiology; D004596:Electroretinography; D005260:Female; D005901:Glaucoma / Q000175:diagnosis* / Q000503:physiopathology*; D006801:Humans; D007429:Intraocular Pressure / Q000502:physiology; D008297:Male; D008875:Middle Aged; D009798:Ocular Hypertension / Q000175:diagnosis / Q000503:physiopathology; D015203:Reproducibility of Results; D012160:Retina / Q000503:physiopathology*; D014065:Tonometry, Ocular; D014792:Visual Acuity / Q000502:physiology; D014794:Visual Fields / Q000502:physiology
references.citation: Ophthalmology. 2008 Jun;115(6):957-63
references.pmid: 17976726
references.citation: Doc Ophthalmol. 1988 Sep;70(1):103-15
references.pmid: 3229288
references.citation: Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1296-302
references.pmid: 15790894
references.citation: Doc Ophthalmol. 2007 May;114(3):111-6
references.pmid: 17435967
references.citation: Ophthalmology. 2004 Jan;111(1):161-8
references.pmid: 14711729
references.citation: Exp Brain Res. 1985;59(2):423-5
references.pmid: 4029317
references.citation: Clin Neurophysiol. 2001 Feb;112(2):351-8
references.pmid: 11165541
references.citation: Ophthalmologica. 1986;192(3):171-5
references.pmid: 3725315
references.citation: Doc Ophthalmol. 1996-1997;92(4):311-23
references.pmid: 9476598
references.citation: Lancet. 1986 Feb 8;1(8476):307-10
references.pmid: 2868172
references.citation: Science. 1981 Feb 27;211(4485):953-5
references.pmid: 7466369
references.citation: Doc Ophthalmol. 1989 Oct;73(2):173-81
references.pmid: 2638626
references.citation: Ophthalmology. 2007 Apr;114(4):671-9
references.pmid: 17398319
references.citation: Am J Ophthalmol. 1983 Jul;96(1):72-83
references.pmid: 6869481
references.citation: Doc Ophthalmol. 1998;95(1):1-14
references.pmid: 10189178
references.citation: Invest Ophthalmol Vis Sci. 1981 Sep;21(3):490-3
references.pmid: 7275535
references.citation: Ophthalmology. 2005 Jan;112(1):10-9
references.pmid: 15629814
references.citation: Invest Ophthalmol Vis Sci. 1999 Mar;40(3):648-56
references.pmid: 10067968
references.citation: Graefes Arch Clin Exp Ophthalmol. 1988;226(6):542-7
references.pmid: 3209081